Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 42Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 14Myeloid 4Thoracic 2Lymphoid 2Sarcoma 1Plasma cell 1Gastrointestinal 1Classical hematology 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 204Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma, T-Cell, Peripheral 29Leukemia, Hairy Cell 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Bronchiolitis Obliterans Syndrome × Lymphoid × Clear all
NCT06335277 2024-03-28

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

European Institute of Oncology

Unknown
50 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Anemia, Aplastic, Leukemia, Lymphoma

NCT02461316 2016-11-02

Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia

Hoffmann-La Roche

Completed
22 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Lymphoid, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡